Publications

A Multi-Site Evaluation to Determine the Performance of the Sensititre YeastOne Susceptibility System using the Sensititre Vizion Compared to a Mirror Read Method, Lead author: Holliday, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Potency of Dalbavancin Tested Against 37,258 Gram-positive Cutaneous Pathogens from USA Medical Centers (2006-2009), Lead author: Jones RN, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Antimicrobial Activity of Daptomycin in Comparison to Glycopeptides and Other Antimicrobials When Tested against Numerous Species of Coagulase-negative Staphylococcus (CoNS), Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

In Vitro Activity of Ceftazidime/NXL104 Against Pathogens Collected During a Phase II Complicated Urinary Tract infection (cUTI) Clinical Trial, Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Activity of AFN-1252, a FabI Inhibitor with Potent Activity against S. aureus and Coagulase-Negative Staphylococcus spp. (CoNS), Including Multidrug-Resistant Strains, Lead author: Biedenbach DJ, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Antimicrobial Activity of Four Oxazolidinone Investigational Compounds Tested against a Collection of Linezolid-non-susceptible Strains with Genetically Defined Resistance Mechanisms, Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

In vitro Activity of a Novel Broad-spectrum Antifungal Agent, E1210, and Comparators Tested against Candida spp., Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Pre-clinical Development of Susceptibility Testing Methods for the Novel Antifungal E1210 Tested against Candida: Comparison of CLSI and EUCAST Methods, Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

In vitro Activity of a Novel Broad-spectrum Antifungal, E1210, Tested against Aspergillus spp. By CLSI and EUCAST Broth Microdilution Methods, Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Profile of Staphylococcus aureus Isolated from United States (USA) Pediatric Patients During the 2009 Ceftaroline AWARE Surveillance Program, Lead author: Krause, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Evaluation of Pneumococci Isolated from United States (USA) Pediatric Patients During the 2009 AWARE Program, Lead author: Krause, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Molecular Identification of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Program, Lead author: Castanheira M, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

Declining MRSA and Fluoroquinolone Resistance Rates Among S. aureus (SA) in the USA: Report from the SENTRY Antimicrobial Surveillance Program (2000–2009), Lead author: Jones RN, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Surveillance of Linezolid Activity against Staphylococci in the United States (USA 2010), Lead author: Ross JE, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Analysis of Linezolid Resistance Mechanisms and Epidemiology of Cfr-producing Strains in the United States, Lead author: Mendes RE, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Carbapenemase Production in United States (USA) Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2009), Lead author: Castanheira M, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

In Vitro Activity Of Anidulafungin and Voriconazole, and Comparators Against Aspergillus spp. as Determined By CLSI And EUCAST Broth Microdilution Methods, Lead author: Pfaller MA, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

An Evaluation of the New Sensititre AIM Performance Compared to the Existing Sensititre Autoinoculator for MIC Determination, Lead author: Killian SB, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

An Evaluation of the New Sensititre OptiRead Performance Compared to the Existing Sensititre AutoReader for MIC Determination, Lead author: Holliday, presented at 111th annual American Society for Microbiology General Meeting (ASM), May 21 – 24, 2011, New Orleans, LA

Antimicrobial Activity of Daptomycin Tested Against S. aureus Collected from Osteoarticular Infections, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Comparison of Tigecycline Activity Tested against Multidrug-resistant Bacteria Isolated from European Medical Centres in Two Time Periods: 2003-2005 and 2008-2010, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Dalbavancin Surveillance Results for European Gram-positive Species (2006-2009) in a Contemporary Sample of 23,825 Strains, Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Dalbavancin Activity and Spectrum Evaluated Against a Contemporary (2007-2009) Worldwide Collection of Staphylococci (62,590 strains), Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Assessment of oritavancin activity tested against beta-haemolytic streptococci responsible for skin and skin structure infections in Europe (2008-2010), Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Analysis of Oritavancin Activity Tested against a Challenge Set of Staphylococcus aureus from Europe (2008-2010), Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Potency of radezolid (RX-1741) and torezolid (DA-7157) tested against a collection of linezolid-non-susceptible strains with genetically defined resistant mechantisms, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity of Solithromycin (CEM-101), a Novel Fluoroketolide Tested against Isolates Collected in Europe during 2010 Surveillance, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary (2010) European Pathogens Isolated from Patients with Community-Acquired Bacterial Pneumonia, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary (2010) European Pathogens Isolated from Patients with Acute Bacterial Skin and Skin-Structure Infections, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of PF-1 and PF-2, Novel Siderophore Conjugated Beta-lactams, Tested Against Enterobacteriaceae Strains Carrying Emerging Resistance Mechanisms, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity and Spectrum of Doripenem against Contemporary (2010) Clinical Bacterial Pathogens from Europe, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Linezolid Susceptibility in Europe for 2010: ZAAPS Program (5,532 strains), Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Ribosomal mutations associated with ketolide resistance in Haemophilus influenzae found in the SENTRY Antimicrobial Surveillance Program, Lead author: Farrell DJ, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Activity of Ceftaroline and Comparator Agents Tested Against Organisms Responsible for Community-Acquired Respiratory Tract Infections in Europe (2009), Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Association of 16S rRNA Methylases and NDM-1 in Isolates from Indian Hospitals Collected in 2006-2007, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

IMP-18-Producing Klebsiella oxytoca, Increasing Genetic Diversity of Metallo-beta-Lactamases in Mexican Hospitals, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Genotypic Evaluation of a Collection of Cfr-producing Staphylococcal Clinical Isolates from the SENTRY Antimicrobial Surveillance Program., Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

NDM-1 in Israel, Evidence of Traveling and Carriage of Carbapenem-Resistant Organisms, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Evaluation of quinolone resistance determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

EUCAST MIC breakpoints and inhibition zone diameter correlates for staphylococci, Lead author: Matuschek, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Susceptibility of Enterococci and Streptococci from United States (USA) Hospitals: A 9-Year Summary of the Daptomycin Surveillance Program (2002-2010), Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial activity and spectrum of daptomycin tested against Gram-positive strains collected in European hospitals: Results from 7 years of surveillance (2003-2009), Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Fusidic Acid Activity and Coverage of Gram-positive Pathogens Associated with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the USA (2008-2010), Lead author: Jones RN, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial Activity of Ceftaroline Tested Against Common Pathogens Causing Complicated Skin and Soft Tissue Infections in European Medical Centres in 2009, Lead author: Sader HS, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Comprehensive analysis of telavancin activity against staphylococcal isolates from Europe (2009-2010), including strains with reduced susceptibility to vancomycin, Lead author: Mendes RE, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Evaluation of L6 ribosomal protein alterations in fusidic acid-resistant Staphylococcus aureus: fitness cost and time-kill analysis, Lead author: Castanheira M, presented at 21st annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 7 – 10, 2011, Milan, Italy

Antimicrobial activty of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes. by Sader HS, Rhomberg PR, Farrell DJ, Jones RN published in Antimicrob. Agents Chemother. 2011; 55 (5): 2390-2394

Molecular typing of antimicrobial-resistant Shiga-toxin-producing Escherichia coli strains (STEC) in Brazil. by Cergole-Novella MC, Pignatari ACC, Castanheira M and Guth BEC published in Res. Microbiol. 2011; 162 (2): 117-123

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the SENTRY Antimicrobial Surveillance Programme (2007-09). by Castanheira M, Mendes RE, Woosley LN and Jones RN published in J. Antimicrob. Chemother. 2011; 66 (6): 1409-1411

Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers. by Sader HS, Farrell DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 69 (2): 223-227